@misc{indiciae13d62bbbb9f6,
  title = {FDA-approved carbonic anhydrase inhibitors reduce Amyloid beta pathology and improve cognition, by ameliorating cerebrovascular health and glial fitness},
  author = {Canepa, E. and Parodi-Rullan, R. and Vazquez-Torres, R. and Gamallo-Lana, B. and Guzman-Hernandez, R. and Lemon, N. L. and Angiulli, F. and Debure, L. and Ilies, M. and Ostergaard, L. and Wisniewski, T. and Gutierrez-Jimenez, E. and Mar, A. and Fossati, S.},
  year = {2022},
  doi = {10.1101/2022.07.19.500681},
  url = {https://www.biorxiv.org/content/10.1101/2022.07.19.500681v1},
  note = {Source identifier: 10.1101/2022.07.19.500681}
}